{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:43:17Z","timestamp":1791726197042,"version":"4.3.4"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1038\/s41581-019-0161-4","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T14:46:46Z","timestamp":1560437206000},"page":"577-589","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":161,"title":["Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease"],"prefix":"10.1038","volume":"15","author":[{"name":"on behalf of the European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders, Dialysis, and Transplantation Working Groups","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Drube","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"Bonthuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"W\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"Grenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Edefonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Harambat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukshana","family":"Shroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"T\u00f6nshoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9601-7813","authenticated-orcid":false,"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,13]]},"reference":[{"key":"161_CR1","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s00467-013-2502-z","volume":"28","author":"D Franke","year":"2013","unstructured":"Franke, D. et al. Growth and maturation improvement in children on renal replacement therapy over the past 20 years. Pediatr. Nephrol. 28, 2043\u20132051 (2013).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2215\/CJN.00890113","volume":"9","author":"J Harambat","year":"2014","unstructured":"Harambat, J. et al. Adult height in patients with advanced CKD requiring renal replacement therapy during childhood. Clin. J. Am. Soc. Nephrol. 9, 92\u201399 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"161_CR3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1053\/ajkd.2000.17674","volume":"36","author":"CS Wong","year":"2000","unstructured":"Wong, C. S. et al. Anthropometric measures and risk of death in children with end-stage renal disease. Am. J. Kidney Dis. 36, 811\u2013819 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"161_CR4","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1542\/peds.109.5.909","volume":"109","author":"SL Furth","year":"2002","unstructured":"Furth, S. L., Stablein, D., Fine, R. N., Powe, N. R. & Fivush, B. A. Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 109, 909\u2013913 (2002).","journal-title":"Pediatrics"},{"key":"161_CR5","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00467-014-2785-8","volume":"29","author":"D Mekahli","year":"2014","unstructured":"Mekahli, D., Ledermann, S., Gullett, A. & Rees, L. Evaluation of quality of life by young adult survivors of severe chronic kidney disease in infancy. Pediatr. Nephrol. 29, 1387\u20131393 (2014).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR6","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jpeds.2013.03.016","volume":"163","author":"A Al-Uzri","year":"2013","unstructured":"Al-Uzri, A. et al. The impact of short stature on health-related quality of life in children with chronic kidney disease. J. Pediatr. 163, 736\u2013741 (2013).","journal-title":"J. Pediatr."},{"key":"161_CR7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00467-005-1821-0","volume":"20","author":"B T\u00f6nshoff","year":"2005","unstructured":"T\u00f6nshoff, B., Kiepe, D. & Ciarmatori, S. Growth hormone\/insulin-like growth factor system in children with chronic renal failure. Pediatr. Nephrol. 20, 279\u2013289 (2005).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR8","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJM200009283431304","volume":"343","author":"D Haffner","year":"2000","unstructured":"Haffner, D. et al. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N. Engl. J. Med. 343, 923\u2013930 (2000).","journal-title":"N. Engl. J. Med."},{"key":"161_CR9","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00467-015-3179-2","volume":"31","author":"L Rees","year":"2016","unstructured":"Rees, L. Growth hormone therapy in children with CKD after more than two decades of practice. Pediatr. Nephrol. 31, 1421\u20131435 (2016).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR10","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00467-006-0020-y","volume":"21","author":"JD Mahan","year":"2006","unstructured":"Mahan, J. D., Warady, B. A. & Consensus Committee. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement. Pediatr. Nephrol. 21, 917\u2013930 (2006).","journal-title":"Pediatr. Nephrol."},{"issue":"Suppl. 3","key":"161_CR11","first-page":"1","volume":"53","author":"National Kidney Foundation","year":"2009","unstructured":"National Kidney Foundation. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Am. J. Kidney Dis. 53 (Suppl. 3), 1\u2013126 (2009).","journal-title":"Am. J. Kidney Dis."},{"key":"161_CR12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/M16-1565","volume":"166","author":"Y Chen","year":"2017","unstructured":"Chen, Y. et al. A reporting tool for practice guidelines in health care: the RIGHT Statement. Ann. Intern. Med. 166, 128\u2013132 (2017).","journal-title":"Ann. Intern. Med."},{"key":"161_CR13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt, G. H. et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J. Clin. Epidemiol. 64, 395\u2013400 (2011).","journal-title":"J. Clin. Epidemiol."},{"key":"161_CR14","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1904","volume":"140","author":"JT Flynn","year":"2017","unstructured":"Flynn, J. T. et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140, e20171904 (2017).","journal-title":"Pediatrics"},{"key":"161_CR15","unstructured":"KHA-CARI. The CARI Guidelines. Evaluation and management of nutrition in children. CARI.org.au http:\/\/www.cari.org.au\/CKD\/CKD%20nutrition%20growth\/Evaluation_and_management_of_nutrition.pdf (2005)."},{"key":"161_CR16","unstructured":"Trace, S. et al. Clinical guideline. Monitoring growth in children with chronic kidney disease. BSPED.org.uk https:\/\/www.bsped.org.uk\/media\/1436\/growthmonitoringinchildrenwithchronickidneydisease.pdf (2018)."},{"key":"161_CR17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ajcn\/80.4.801","volume":"80","author":"BJ Foster","year":"2004","unstructured":"Foster, B. J. & Leonard, M. B. Measuring nutritional status in children with chronic kidney disease. Am. J. Clin. Nutr. 80, 801\u2013814 (2004).","journal-title":"Am. J. Clin. Nutr."},{"issue":"Suppl. 5","key":"161_CR18","first-page":"1229","volume":"15","author":"JM Wit","year":"2002","unstructured":"Wit, J. M. & Boersma, B. Catch-up growth: definition, mechanisms, and models. J. Pediatr. Endocrinol. Metab. 15 (Suppl. 5), 1229\u20131241 (2002).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"161_CR19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042506","volume":"7","author":"M Bonthuis","year":"2012","unstructured":"Bonthuis, M. et al. Use of national and international growth charts for studying height in European children: development of up-to-date European height-for-age charts. PLOS ONE 7, e42506 (2012).","journal-title":"PLOS ONE"},{"key":"161_CR20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/2230-8210.145076","volume":"18","author":"V De Sanctis","year":"2014","unstructured":"De Sanctis, V. et al. Hand X-ray in pediatric endocrinology: skeletal age assessment and beyond. Indian J. Endocrinol. Metab. 18, 63\u201371 (2014).","journal-title":"Indian J. Endocrinol. Metab."},{"key":"161_CR21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/adc.51.3.170","volume":"51","author":"JM Tanner","year":"1976","unstructured":"Tanner, J. M. & Whitehouse, R. H. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch. Dis. Child. 51, 170\u2013179 (1976).","journal-title":"Arch. Dis. Child"},{"key":"161_CR22","doi-asserted-by":"crossref","unstructured":"Molinari, L., Largo, R. H. & Prader, A. in Human Growth and Development (ed. Borms, J.) 193\u2013200 (Springer, 1985).","DOI":"10.1007\/978-1-4757-0743-4_21"},{"key":"161_CR23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1203\/00006450-199007000-00002","volume":"28","author":"F Schaefer","year":"1990","unstructured":"Schaefer, F. & Seidel, C. et al. Pubertal growth in chronic renal failure. Pediatr. Res. 28, 5\u201310 (1990).","journal-title":"Pediatr. Res."},{"key":"161_CR24","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1523-1755.2004.00805.x","volume":"66","author":"R Nissel","year":"2004","unstructured":"Nissel, R. et al. Effect of renal transplantation in childhood on longitudinal growth and adult height. Kidney Int. 66, 792\u2013800 (2004).","journal-title":"Kidney Int."},{"key":"161_CR25","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrneph.2011.137","volume":"7","author":"L Rees","year":"2011","unstructured":"Rees, L. & Mak, R. Nutrition and growth in children with chronic kidney disease. Nat. Rev. Nephrol. 7, 615\u2013623 (2011).","journal-title":"Nat. Rev. Nephrol."},{"key":"161_CR26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/nu7010517","volume":"7","author":"G Gat-Yablonski","year":"2015","unstructured":"Gat-Yablonski, G. & Phillip, M. Nutritionally-induced catch-up growth. Nutrients 7, 517\u2013551 (2015).","journal-title":"Nutrients"},{"key":"161_CR27","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1046\/j.1523-1755.2000.00013.x","volume":"57","author":"JA Kari","year":"2000","unstructured":"Kari, J. A., Gonzalez, C., Ledermann, S. E., Shaw, V. & Rees, L. Outcome and growth of infants with severe chronic renal failure. Kidney Int. 57, 1681\u20131687 (2000).","journal-title":"Kidney Int."},{"key":"161_CR28","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2215\/CJN.07791109","volume":"5","author":"F Santos","year":"2010","unstructured":"Santos, F. et al. Improvement in growth after 1 year of growth hormone therapy in well-nourished infants with growth retardation secondary to chronic renal failure: results of a multicenter, controlled, randomized, open clinical trial. Clin. J. Am. Soc. Nephrol. 5, 1190\u20131197 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"161_CR29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00467-016-3432-3","volume":"32","author":"D Haffner","year":"2017","unstructured":"Haffner, D. & Zivicnjak, M. Pubertal development in children with chronic kidney disease. Pediatr. Nephrol. 32, 949\u2013964 (2017).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR30","unstructured":"Blum, W. F. et al. Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr. Nephrol. 5, 539\u2013544 (1991)."},{"key":"161_CR31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pcl.2018.08.010","volume":"66","author":"R Fulchiero","year":"2019","unstructured":"Fulchiero, R. & Seo-Mayer, P. Bartter syndrome and Gitelman syndrome. Pediatr. Clin. North Am. 66, 121\u2013134 (2019).","journal-title":"Pediatr. Clin. North Am."},{"key":"161_CR32","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s00467-008-0844-8","volume":"23","author":"H Lejarraga","year":"2008","unstructured":"Lejarraga, H., Caletti, M. G., Caino, S. & Jim\u00e9nez, A. Long-term growth of children with nephrogenic diabetes insipidus. Pediatr. Nephrol. 23, 2007\u20132012 (2008).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pcl.2018.08.011","volume":"66","author":"RT Alexander","year":"2019","unstructured":"Alexander, R. T. & Bitzan, M. Renal tubular acidosis. Pediatr. Clin. North Am. 66, 135\u2013157 (2019).","journal-title":"Pediatr. Clin. North Am."},{"key":"161_CR34","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00467-014-2812-9","volume":"29","author":"NM Rodig","year":"2014","unstructured":"Rodig, N. M. et al. Growth in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children Study. Pediatr. Nephrol. 29, 1987\u20131995 (2014).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR35","first-page":"S1","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl. 113, S1\u2013S130 (2009).","journal-title":"Kidney Int. Suppl."},{"key":"161_CR36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00467-005-2082-7","volume":"21","author":"G Klaus","year":"2006","unstructured":"Klaus, G. et al. Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr. Nephrol. 21, 151\u2013159 (2006).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00467-012-2270-1","volume":"28","author":"D Haffner","year":"2013","unstructured":"Haffner, D. & Schaefer, F. Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies. Pediatr. Nephrol. 28, 537\u2013545 (2013).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR38","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/ndt\/gfx080","volume":"32","author":"R Shroff","year":"2017","unstructured":"Shroff, R. et al. Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2-5 and on dialysis. Nephrol. Dial. Transplant. 32, 1098\u20131113 (2017).","journal-title":"Nephrol. Dial. Transplant."},{"key":"161_CR39","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1681\/ASN.2010020192","volume":"22","author":"L Rees","year":"2011","unstructured":"Rees, L. et al. Growth in very young children undergoing chronic peritoneal dialysis. J. Am. Soc. Nephrol. 22, 2303\u20132312 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"161_CR40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0022-3476(99)70205-2","volume":"134","author":"A Tom","year":"1999","unstructured":"Tom, A. et al. Growth during maintenance hemodialysis: impact of enhanced nutrition and clearance. J. Pediatr. 134, 464\u2013471 (1999).","journal-title":"J. Pediatr."},{"key":"161_CR41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ki.1992.277","volume":"42","author":"RN Fine","year":"1992","unstructured":"Fine, R. N. Stimulating growth in uremic children. Kidney Int. 42, 188\u2013197 (1992).","journal-title":"Kidney Int."},{"key":"161_CR42","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00467-007-0472-8","volume":"22","author":"M Boehm","year":"2007","unstructured":"Boehm, M. et al. Early erythropoietin therapy is associated with improved growth in children with chronic kidney disease. Pediatr. Nephrol. 22, 1189\u20131193 (2007).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ki.2013.444","volume":"85","author":"A Levin","year":"2014","unstructured":"Levin, A. & Stevens, P. E. Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 85, 49\u201361 (2014).","journal-title":"Kidney Int."},{"key":"161_CR44","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1515\/JPEM.2011.319","volume":"24","author":"R Noto","year":"2011","unstructured":"Noto, R. et al. Intracranial hypertension in pediatric patients treated with recombinant human growth hormone: data from 25 years of the Genentech national cooperative growth study. J. Pediatr. Endocrinol. Metab. 24, 627\u2013631 (2011).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"161_CR45","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1203\/00006450-198209000-00016","volume":"16","author":"RW Jones","year":"1982","unstructured":"Jones, R. W., Rigden, S. P., Barratt, T. M. & Chantler, C. The effects of chronic renal failure in infancy on growth, nutritional status and body composition. Pediatr. Res. 16, 784\u2013791 (1982).","journal-title":"Pediatr. Res."},{"key":"161_CR46","first-page":"S40","volume":"15","author":"C Kleinknecht","year":"1983","unstructured":"Kleinknecht, C., Broyer, M., Huot, D., Marti-Henneberg, C. & Dartois, A. M. Growth and development of nondialyzed children with chronic renal failure. Kidney Int. Suppl. 15, S40\u2013S47 (1983).","journal-title":"Kidney Int. Suppl."},{"key":"161_CR47","first-page":"CD003264","volume":"2","author":"EM Hodson","year":"2012","unstructured":"Hodson, E. M., Willis, N. S. & Craig, J. C. Growth hormone for children with chronic kidney disease. Cochrane Database Syst. Rev. 2, CD003264 (2012).","journal-title":"Cochrane Database Syst. Rev."},{"key":"161_CR48","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0022-3476(94)70358-2","volume":"124","author":"RN Fine","year":"1994","unstructured":"Fine, R. N., Kohaut, E. C., Brown, D. & Perlman, A. J. Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group. J. Pediatr. 124, 374\u2013382 (1994).","journal-title":"J. Pediatr."},{"key":"161_CR49","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00467-012-2258-x","volume":"28","author":"L Rees","year":"2013","unstructured":"Rees, L. & Jones, H. Nutritional management and growth in children with chronic kidney disease. Pediatr. Nephrol. 28, 527\u2013536 (2013).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR50","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1067\/mpd.2001.113263","volume":"138","author":"E W\u00fchl","year":"2001","unstructured":"W\u00fchl, E. et al. Long-term treatment with growth hormone in short children with nephropathic cystinosis. J. Pediatr. 138, 880\u2013887 (2001).","journal-title":"J. Pediatr."},{"key":"161_CR51","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1681\/ASN.V9101899","volume":"9","author":"D Haffner","year":"1998","unstructured":"Haffner, D. et al. Factors predictive of the short- and long-term efficacy of growth hormone treatment in prepubertal children with chronic renal failure. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure. J. Am. Soc. Nephrol. 9, 1899\u20131907 (1998).","journal-title":"J. Am. Soc. Nephrol."},{"key":"161_CR52","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s004670000340","volume":"14","author":"A Hokken-Koelega","year":"2000","unstructured":"Hokken-Koelega, A. et al. Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency. Pediatr. Nephrol. 14, 701\u2013706 (2000).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR53","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ki.1996.108","volume":"49","author":"RN Fine","year":"1996","unstructured":"Fine, R. N., Kohaut, E., Brown, D., Kuntze, J. & Attie, K. M. Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone. Kidney Int. 49, 781\u2013785 (1996).","journal-title":"Kidney Int."},{"key":"161_CR54","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF00866763","volume":"10","author":"E W\u00fchl","year":"1996","unstructured":"W\u00fchl, E., Haffner, D., Nissel, R., Schaefer, F. & Mehls, O. Short dialyzed children respond less to growth hormone than patients prior to dialysis. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr. Nephrol. 10, 294\u2013298 (1996).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR55","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/ndt\/gfp565","volume":"25","author":"M Fischbach","year":"2010","unstructured":"Fischbach, M. et al. Daily on line haemodiafiltration promotes catch-up growth in children on chronic dialysis. Nephrol. Dial. Transplant. 25, 867\u2013873 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"161_CR56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/j.jrn.2010.10.022","volume":"21","author":"M Fischbach","year":"2011","unstructured":"Fischbach, M., Fothergill, H., Seuge, L. & Zaloszyc, A. Dialysis strategies to improve growth in children with chronic kidney disease. J. Ren. Nutr. 21, 43\u201346 (2011).","journal-title":"J. Ren. Nutr."},{"key":"161_CR57","doi-asserted-by":"crossref","first-page":"824","DOI":"10.2215\/CJN.00330112","volume":"8","author":"J Bacchetta","year":"2013","unstructured":"Bacchetta, J. et al. The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial. Clin. J. Am. Soc. Nephrol. 8, 824\u2013832 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"161_CR58","first-page":"176","volume":"1","author":"B T\u00f6nshoff","year":"1997","unstructured":"T\u00f6nshoff, B. & Mehls, O. Factors affecting growth and strategies for treatment in children after renal transplantation. Pediatr. Transplant. 1, 176\u2013182 (1997).","journal-title":"Pediatr. Transplant."},{"key":"161_CR59","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00467-009-1387-3","volume":"25","author":"RN Fine","year":"2010","unstructured":"Fine, R. N., Martz, K. & Stablein, D. What have 20\u00a0years of data from the North American Pediatric Renal Transplant Cooperative Study taught us about growth following renal transplantation in infants, children, and adolescents with end-stage renal disease? Pediatr. Nephrol. 25, 739\u2013746 (2010).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR60","volume":"11","author":"H Zhang","year":"2016","unstructured":"Zhang, H. et al. Steroid avoidance or withdrawal regimens in paediatric kidney transplantation: a meta-analysis of randomised controlled trials. PLOS ONE 11, e0146523 (2016).","journal-title":"PLOS ONE"},{"key":"161_CR61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00467-012-2208-7","volume":"28","author":"Y Wu","year":"2013","unstructured":"Wu, Y., Cheng, W., Yang, X. D. & Xiang, B. Growth hormone improves growth in pediatric renal transplant recipients-a systemic review and meta-analysis of randomized controlled trials. Pediatr. Nephrol. 28, 129\u2013133 (2013).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR62","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00467-004-1688-5","volume":"20","author":"RN Fine","year":"2005","unstructured":"Fine, R. N. & Stablein, D. Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry. Pediatr. Nephrol. 20, 404\u2013408 (2005).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR63","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00467-008-1084-7","volume":"24","author":"F Mencarelli","year":"2009","unstructured":"Mencarelli, F. et al. Growth hormone treatment started in the first year of life in infants with chronic renal failure. Pediatr. Nephrol. 24, 1039\u20131046 (2009).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR64","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00467-009-1190-1","volume":"24","author":"D Franke","year":"2009","unstructured":"Franke, D., Zivicnjak, M. & Ehrich, J. H. Growth hormone treatment of renal growth failure during infancy and early childhood. Pediatr. Nephrol. 24, 1093\u20131096 (2009).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR65","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(94)92465-1","volume":"343","author":"AC Hokken-Koelega","year":"1994","unstructured":"Hokken-Koelega, A. C. et al. Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet 343, 1313\u20131317 (1994).","journal-title":"Lancet"},{"key":"161_CR66","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00467-017-3777-2","volume":"33","author":"S Gil","year":"2018","unstructured":"Gil, S., Aziz, M., Adragna, M., Monteverde, M. & Belgorosky, A. Near-adult height in male kidney transplant recipients started on growth hormone treatment in late puberty. Pediatr. Nephrol. 33, 175\u2013180 (2018).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR67","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1210\/jc.2007-2302","volume":"93","author":"R Nissel","year":"2008","unstructured":"Nissel, R., Lindberg, A., Mehls, O., Haffner, D. & Pfizer International Growth Database (KIGS) International Board. Factors predicting the near-final height in growth hormone-treated children and adolescents with chronic kidney disease. J. Clin. Endocrinol. Metab. 93, 1359\u20131365 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"161_CR68","first-page":"128","volume":"53","author":"AC Hokken-Koelega","year":"1996","unstructured":"Hokken-Koelega, A. C. et al. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant. Kidney Int. Suppl. 53, 128\u2013134 (1996).","journal-title":"Kidney Int. Suppl."},{"key":"161_CR69","first-page":"190","volume":"1","author":"F Janssen","year":"1997","unstructured":"Janssen, F. et al. Impact of growth hormone treatment on a belgian population of short children with renal allografts. Pediatr. Transplant. 1, 190\u2013196 (1997).","journal-title":"Pediatr. Transplant."},{"key":"161_CR70","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s004670000383","volume":"14","author":"RN Fine","year":"2000","unstructured":"Fine, R. N., Sullivan, E. K. & Tejani, A. The impact of recombinant human growth hormone treatment on final adult height. Pediatr. Nephrol. 14, 679\u2013681 (2000).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR71","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s004670050765","volume":"14","author":"L Rees","year":"2000","unstructured":"Rees, L., Ward, G. & Rigden, S. P. Growth over 10\u00a0years following a 1-year trial of growth hormone therapy. Pediatr. Nephrol. 14, 309\u2013314 (2000).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR72","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00467-008-0849-3","volume":"23","author":"E Berard","year":"2008","unstructured":"Berard, E. et al. Long-term results of rhGH treatment in children with renal failure: experience of the French Society of Pediatric Nephrology. Pediatr. Nephrol. 23, 2031\u20132038 (2008).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR73","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/ki.2010.316","volume":"78","author":"D Borzych","year":"2010","unstructured":"Borzych, D. et al. The bone and mineral disorder of children undergoing chronic peritoneal dialysis. Kidney Int. 78, 1295\u20131304 (2010).","journal-title":"Kidney Int."},{"key":"161_CR74","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00866781","volume":"10","author":"SL Watkins","year":"1996","unstructured":"Watkins, S. L. Is severe renal osteodystrophy a contraindication for recombinant human growth hormone treatment? Pediatr. Nephrol. 10, 351\u2013354 (1996).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR75","unstructured":"European Medicines Agency. Summary of product characteristics. EMA https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/omnitrope-epar-product-information_en.pdf (updated 6 Mar 2018)."},{"key":"161_CR76","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0140-6736(91)90604-N","volume":"338","author":"AC Hokken-Koelega","year":"1991","unstructured":"Hokken-Koelega, A. C. et al. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 338, 585\u2013590 (1991).","journal-title":"Lancet"},{"key":"161_CR77","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1651-2227.1996.tb14304.x","volume":"417","author":"M Broyer","year":"1996","unstructured":"Broyer, M. Results and side-effects of treating children with growth hormone after kidney transplantation \u2014 a preliminary report. Pharmacia & Upjohn Study Group. Acta Paediatr. Suppl. 417, 76\u201379 (1996).","journal-title":"Acta Paediatr. Suppl."},{"key":"161_CR78","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1523-1755.2002.00489.x","volume":"62","author":"RN Fine","year":"2002","unstructured":"Fine, R. N. et al. Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS. Kidney Int. 62, 688\u2013696 (2002).","journal-title":"Kidney Int."},{"key":"161_CR79","first-page":"546","volume":"9","author":"BD Kuizon","year":"1998","unstructured":"Kuizon, B. D., Goodman, W. G., Gales, B., Juppner, H. & Salusky, I. B. Effects of growth hormone on bone and mineral metabolism in dialyzed children [abstract]. J. Am. Soc. Nephrol. 9, 546\u2013547 (1998).","journal-title":"J. Am. Soc. Nephrol."},{"key":"161_CR80","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/adc.79.6.481","volume":"79","author":"H Maxwell","year":"1998","unstructured":"Maxwell, H. & Rees, L. Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. Arch. Dis. Child. 79, 481\u2013487 (1998).","journal-title":"Arch. Dis. Child."},{"key":"161_CR81","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/ki.1997.268","volume":"51","author":"DR Powell","year":"1997","unstructured":"Powell, D. R. et al. Modulation of growth factors by growth hormone in children with chronic renal failure. The Southwest Pediatric Nephrology Study Group. Kidney Int. 51, 1970\u20131979 (1997).","journal-title":"Kidney Int."},{"key":"161_CR82","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00467-002-0824-3","volume":"17","author":"CP Sanchez","year":"2002","unstructured":"Sanchez, C. P. et al. Growth hormone and the skeleton in pediatric renal allograft recipients. Pediatr. Nephrol. 17, 322\u2013328 (2002).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR83","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF00866726","volume":"9","author":"RN Fine","year":"1995","unstructured":"Fine, R. N., Attie, K. M., Kuntze, J., Brown, D. F. & Kohaut, E. C. Recombinant human growth hormone in infants and young children with chronic renal insufficiency. Genentech Collaborative Study Group. Pediatr. Nephrol. 9, 451\u2013457 (1995).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR84","first-page":"328","volume":"45","author":"LL Callis","year":"1996","unstructured":"Callis, L. L. et al. Randomized open multicentre study to assess treatment with recombinant human growth hormone in children with low height and chronic renal insufficiency [abstract]. An. Esp. Pediatr. 45, 328 (1996).","journal-title":"An. Esp. Pediatr."},{"key":"161_CR85","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1515\/JPEM.2002.15.5.577","volume":"15","author":"NT Hertel","year":"2002","unstructured":"Hertel, N. T. et al. Recombinant human growth hormone treatment, using two dose regimens in children with chronic renal failure\u2014a report on linear growth and adverse effects. J. Pediatr. Endocrinol. Metab. 15, 577\u2013588 (2002).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"161_CR86","first-page":"1185","volume":"79","author":"AC Hokken-Koelega","year":"1994","unstructured":"Hokken-Koelega, A. C. et al. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency. J. Clin. Endocrinol. Metab. 79, 1185\u20131190 (1994).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"161_CR87","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1297\/cpe.6.Supple9_49","volume":"6","author":"K Ito","year":"1997","unstructured":"Ito, K. & Kawaguchi, H. The use of recombinant human GH (rhGH) in growth failure in children with various renal diseases. Clin. Pediatr. Endocrinol. 6, 49\u201353 (1997).","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"161_CR88","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1297\/cpe.6.Supple10_73","volume":"6","author":"T Kitagawa","year":"1997","unstructured":"Kitagawa, T. et al. GH treatment of children with chronic renal insufficiency: a Japanese clinical trial. Clin. Pediatr. Endocrinol. 6, 73\u201380 (1997).","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"161_CR89","unstructured":"Pfizer. Genotropin\u00ae (somatropin): highlights of prescribing information. Pfizer https:\/\/www.pfizermedicalinformation.com\/en-us\/genotropin (2019)."},{"key":"161_CR90","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2147\/DDDT.S130317","volume":"11","author":"P Saenger","year":"2017","unstructured":"Saenger, P. Ten years of biosimilar recombinant human growth hormone in Europe. Drug Des. Devel. Ther. 11, 1505\u20131507 (2017).","journal-title":"Drug Des. Devel. Ther."},{"key":"161_CR91","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mpd.2003.189","volume":"142","author":"RN Fine","year":"2003","unstructured":"Fine, R. N., Ho, M., Tejani, A. & Blethen, S. Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease. J.\u00a0Pediatr. 142, 539\u2013545 (2003).","journal-title":"J. Pediatr."},{"key":"161_CR92","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1203\/00006450-199802000-00009","volume":"43","author":"D Haffner","year":"1998","unstructured":"Haffner, D. et al. Metabolic effects of long-term growth hormone treatment in prepubertal children with chronic renal failure and after kidney transplantation. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr. Res. 43, 209\u2013215 (1998).","journal-title":"Pediatr. Res."},{"key":"161_CR93","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s004310050926","volume":"157","author":"G Filler","year":"1998","unstructured":"Filler, G., Amendt, P., von Bredow, M. A., Rohde, W. & Ehrich, J. H. Slowly deteriorating insulin secretion and C-peptide production characterizes diabetes mellitus in infantile cystinosis. Eur. J. Pediatr. 157, 738\u2013742 (1998).","journal-title":"Eur. J. Pediatr."},{"key":"161_CR94","doi-asserted-by":"crossref","first-page":"422","DOI":"10.7326\/M17-2640","volume":"168","author":"M Ketteler","year":"2018","unstructured":"Ketteler, M. et al. Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update. Ann. Intern. Med. 168, 422\u2013430 (2018).","journal-title":"Ann. Intern. Med."},{"key":"161_CR95","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s00467-015-3157-8","volume":"30","author":"O Mehls","year":"2015","unstructured":"Mehls, O. et al. Long-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and ESCAPE trial. Pediatr. Nephrol. 30, 2145\u20132151 (2015).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR96","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1399-3046.2007.00881.x","volume":"12","author":"VR Dharnidharka","year":"2008","unstructured":"Dharnidharka, V. R., Talley, L. I., Martz, K. L., Stablein, D. M. & Fine, R. N. Recombinant growth hormone use pretransplant and risk for post-transplant lymphoproliferative disease-a report of the NAPRTCS. Pediatr. Transplant. 12, 689\u2013695 (2008).","journal-title":"Pediatr. Transplant."},{"key":"161_CR97","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s00467-002-0962-7","volume":"17","author":"O Mehls","year":"2002","unstructured":"Mehls, O. et al. Does growth hormone treatment affect the risk of post-transplant renal cancer? Pediatr. Nephrol. 17, 984\u2013989 (2002).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR98","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/petr.12167","volume":"17","author":"DK Longmore","year":"2013","unstructured":"Longmore, D. K., Conwell, L. S., Burke, J. R., McDonald, S. P. & McTaggart, S. J. Post-transplant lymphoproliferative disorder: no relationship to recombinant human growth hormone use in Australian and New Zealand pediatric kidney transplant recipients. Pediatr. Transplant. 17, 731\u2013736 (2013).","journal-title":"Pediatr. Transplant."},{"key":"161_CR99","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0022-3476(96)70033-1","volume":"129","author":"RN Fine","year":"1996","unstructured":"Fine, R. N. Growth after discontinuation of recombinant human growth hormone therapy in children with chronic renal insufficiency. J. Pediatr. 129, 883\u2013891 (1996).","journal-title":"J. Pediatr."},{"key":"161_CR100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ccc.2005.09.003","volume":"22","author":"T Teng Chung","year":"2006","unstructured":"Teng Chung, T. & Hinds, C. J. Treatment with GH and IGF-1 in critical illness. Crit. Care Clin. 22, 29\u201340 (2006).","journal-title":"Crit. Care Clin."},{"key":"161_CR101","first-page":"CD008990","volume":"9","author":"RS Breederveld","year":"2014","unstructured":"Breederveld, R. S. & Tuinebreijer, W. E. Recombinant human growth hormone for treating burns and donor sites. Cochrane Database Syst. Rev. 9, CD008990 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"161_CR102","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM199909093411102","volume":"341","author":"J Takala","year":"1999","unstructured":"Takala, J. et al. Increased mortality associated with growth hormone treatment in critically ill adults. N.\u00a0Engl. J. Med. 341, 785\u2013792 (1999).","journal-title":"N. Engl. J. Med."},{"key":"161_CR103","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/ki.1996.199","volume":"49","author":"GT Kovacs","year":"1996","unstructured":"Kovacs, G. T. et al. Growth promoting effects of growth hormone and IGF-I are additive in experimental uremia. Kidney Int. 49, 1413\u20131421 (1996).","journal-title":"Kidney Int."},{"key":"161_CR104","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00467-012-2271-0","volume":"28","author":"C Farquharson","year":"2013","unstructured":"Farquharson, C. & Ahmed, S. F. Inflammation and linear bone growth: the inhibitory role of SOCS2 on GH\/IGF-1 signaling. Pediatr. Nephrol. 28, 547\u2013556 (2013).","journal-title":"Pediatr. Nephrol."},{"key":"161_CR105","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1210\/jc.2007-1559","volume":"93","author":"N Mauras","year":"2008","unstructured":"Mauras, N. et al. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years. J. Clin. Endocrinol. Metab. 93, 823\u2013831 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"161_CR106","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00467-006-0345-6","volume":"22","author":"M Zivicnjak","year":"2007","unstructured":"Zivicnjak, M. et al. Growth impairment shows an age-dependent pattern in boys with chronic kidney disease. Pediatr. Nephrol. 22, 420\u2013429 (2007).","journal-title":"Pediatr. Nephrol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41581-019-0161-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41581-019-0161-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41581-019-0161-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:08:32Z","timestamp":1684620512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-019-0161-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,13]]},"references-count":106,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1038\/s41581-019-0161-4","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,13]]},"assertion":[{"value":"24 April 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.B. has received speaker fees from Pfizer. B.T. has received grant support from Astellas, Novartis, Roche and Bristol-Myers Squibb and received speaker fees from Bristol-Meyers Squibb. D.H. has received research grants from Sandoz, Kyowa Kirin, Horizon and Amgen and has received speaker and\/or consultant fees from Amgen, Sandoz, Kyowa Kirn, Pfizer, Merck Serono, Horizon and Chiesi. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}